Access this stock data via API
Subscribe
Astellas Pharma Inc.
0
0
0%

Financials

Income statement

Fiscal date 2025 2024 2023 2022
Total reported revenue 1.9T 1.6T 1.5T 1.3T
Cost of revenue 349.2B 292.5B 288.4B 253.0B
Gross profit 1.6T 1.3T 1.2T 1.0T
Operating expense
Research & development 327.7B 294.2B 276.1B 246.0B
Selling general and admin 843.0B 740.1B 630.3B 548.8B
Other operating expenses 235.8B 167.8B 157.5B 104.3B
Operating income 40.2B 18.9B 131.6B 131.0B
Non operating interest income
Income 7.9B 11.5B 8.1B 6.1B
Expense 17.7B 12.0B 8.8B 4.9B
Other income expense
Pretax income 31.2B 25.0B 132.4B 156.9B
Tax provision -19.5B 7.9B 33.6B 32.8B
Net income 50.7B 17.0B 98.7B 124.1B
Basic EPS 28.4 9.5 54.2 67.1
Diluted EPS 28.2 9.5 54.1 67.1
Basic average shares 1.8B 1.8B 1.8B 1.8B
Diluted average shares 1.8B 1.8B 1.8B 1.8B
EBITDA 247.0B 185.1B 246.7B 217.3B
Net income from continuing op. 31.2B 25.0B 132.4B 156.9B
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 9 hours 51 minutes

23:08
00:00
09:00
15:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 15:30
All times are displayed in the Asia/Tokyo timezone (JST, UTC+09:00).